advanced search

Welcome: Guest

log in

0 items in basket Total: £0
$0 / €0

View Basket

Healthcare Market Research

Get the necessary research you need for the Healthcare Industry. Our catalogue of reports provides information on health maintenance organisations (HMO), Hospitals and Healthcare Insurance.

Stay up-to-date with new products added to this category
Title Date Price
Progenics Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile
Jul 2009 £155
Enzon Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile
Jul 2009 £155
ZymoGenetics, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile
Jul 2009 £155
ViroPharma Incorporated - Pharmaceuticals & Healthcare
Deals and Alliances Profile
Jul 2009 £155
Vertex Pharmaceuticals Incorporated - Pharmaceuticals & Healthcare
Deals and Alliances Profile
Jul 2009 £155
Indevus Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile
Jul 2009 £155
Arpida Ltd. - Pharmaceuticals & Healthcare
Deals and Alliances Profile
Jul 2009 £155
Prefeasibility Report - Specaility and Multi- Speciality Hospitals
2009
Jul 2009 £780
Genta Incorporated - Pharmaceuticals & Healthcare
Deals and Alliances Profile
Jul 2009 £155
The Biggest Acute Hospitals In Ireland
Jul 2009 £255
Alfacell Corporation - Pharmaceuticals & Healthcare
Deals and Alliances Profile
Jul 2009 £155
Biodel Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile
Jul 2009 £155
SuperGen, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile
Jul 2009 £155
Javelin Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile
Jul 2009 £155
InterMune, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile
Jul 2009 £155
Les Laboratoires Servier - Pharmaceuticals & Healthcare
Deals and Alliances Profile
Jul 2009 £155
GTx, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile
Jul 2009 £155
Sunesis Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile
Jul 2009 £155
GTC Biotherapeutics, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile
Jul 2009 £155
Maxygen, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile
Jul 2009 £155
King Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile
Jul 2009 £155
Salix Pharmaceuticals, Ltd. - Pharmaceuticals & Healthcare
Deals and Alliances Profile
Jul 2009 £155
Santarus, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile
Jul 2009 £155
Savient Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile
Jul 2009 £155
Rigel Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile
Jul 2009 £155
Noven Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile
Jul 2009 £155
Altus Pharmaceuticals Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Labopharm Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
CIGNA Corporation - Financial and Strategic Analysis Review
Jun 2009 £77
Adherex Technologies Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
BioSante Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Accelrys, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Nektar Therapeutics - Financial and Strategic Analysis Review
Jun 2009 £77
Actelion Ltd - Financial and Strategic Analysis Review
Jun 2009 £77
GPC Biotech AG - Financial and Strategic Analysis Review
Jun 2009 £77
Vasogen Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Albany Molecular Research, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Monogram Biosciences, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
LifePoint Hospitals, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
MedCath Corporation - Financial and Strategic Analysis Review
Jun 2009 £77
Southern Cross Healthcare Group PLC - Financial and Strategic Analysis Review
Jun 2009 £77
Triple-S Management Corporation - Financial and Strategic Analysis Review
Jun 2009 £77
Universal American Corp. - Financial and Strategic Analysis Review
Jun 2009 £77
Neurocrine Biosciences, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Cubist Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Anesiva, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
CuraGen Corporation - Financial and Strategic Analysis Review
Jun 2009 £77
Depomed, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Cephalon, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Celesio AG - Financial and Strategic Analysis Review
Jun 2009 £77
Auxilium Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
BioMarin Pharmaceutical Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Boiron SA - Financial and Strategic Analysis Review
Jun 2009 £77
Discovery Laboratories, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Elan Corporation, plc - Financial and Strategic Analysis Review
Jun 2009 £77
Genomic Health, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
China Sky One Medical, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Alexza Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
AspenBio Pharma, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
deCODE genetics, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
AMDL, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
eResearchTechnology, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Ark Therapeutics Group plc - Financial and Strategic Analysis Review
Jun 2009 £77
Covance Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
GenVec, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Medicis Pharmaceutical Corporation - Financial and Strategic Analysis Review
Jun 2009 £77
CVS Caremark Corporation - Financial and Strategic Analysis Review
Jun 2009 £77
Gilead Sciences, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Antigenics, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
CML Healthcare Income Fund - Financial and Strategic Analysis Review
Jun 2009 £77
Avigen, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
BioDelivery Sciences International, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Infinity Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
GeoVax Labs, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Micromet, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Community Health Centres in Australia
IBISWorld Industry Report
Jun 2009 £380
Multichannel Retail: Using Integrated Technology to Achieve Cross-Channel Brand Consistency
Jun 2009 £2,400
Intuitive Surgical, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Antares Pharma, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Amgen Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Cerus Corporation - Financial and Strategic Analysis Review
Jun 2009 £77
Chembio Diagnostic, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
BioSphere Medical, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Novo Nordisk A/S - Financial and Strategic Analysis Review
Jun 2009 £77
Cepheid - Financial and Strategic Analysis Review
Jun 2009 £77
Grifols, S.A. - Financial and Strategic Analysis Review
Jun 2009 £77
Emergent BioSolutions Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Caliper Life Sciences Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Alseres Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Chelsea Therapeutics International, Ltd. - Financial and Strategic Analysis Review
Jun 2009 £77
Epigenomics AG - Financial and Strategic Analysis Review
Jun 2009 £77
QLT Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Cytori Therapeutics, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Echo Therapeutics, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Inovio Biomedical Corporation - Financial and Strategic Analysis Review
Jun 2009 £77
Clarient, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
AstraZeneca PLC - Financial and Strategic Analysis Review
Jun 2009 £77
Illumina, Inc. - Financial and Strategic Analysis Review
Jun 2009 £77
Neoprobe Corporation - Financial and Strategic Analysis Review
Jun 2009 £77
Perot Systems Corporation - Financial and Strategic Analysis Review
Jun 2009 £77

Industry Events

Advancing Biologics from the Lab to the Clinic

11 Jan 10 to 12 Jan 10
Brussels, Belgium
view summary >>

Oncology Market & Patient Access

14 Dec 09 to 16 Dec 09
Prague, Czech Republic
view summary >>

Innovations in Oncology Drug Discovery, Development & Delivery

01 Dec 09 to 01 Dec 09
N/A, UK
view summary >>

Pharma & Healthcare

Customer Services

How To Buy
Formats & Delivery
Terms & Conditions
Account Options
Login/Register

call +44 (0) 20 7060 7474
or email us

Post it

Del.icio.us
StumbleUpon
Reddit

logo: AddThis